000 | 01958 a2200565 4500 | ||
---|---|---|---|
005 | 20250516171236.0 | ||
264 | 0 | _c20141006 | |
008 | 201410s 0 0 eng d | ||
022 | _a1613-4133 | ||
024 | 7 |
_a10.1002/mnfr.201300272 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCheong, Sun Hee | |
245 | 0 | 0 |
_aAntihyperglycemic effect of equol, a daidzein derivative, in cultured L6 myocytes and ob/ob mice. _h[electronic resource] |
260 |
_bMolecular nutrition & food research _cFeb 2014 |
||
300 |
_a267-77 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAMP-Activated Protein Kinases _xgenetics |
650 | 0 | 4 |
_aAdiponectin _xblood |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aChemokine CCL2 _xblood |
650 | 0 | 4 |
_aCholesterol _xblood |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
650 | 0 | 4 |
_aEquol _xpharmacology |
650 | 0 | 4 |
_aGlucose Intolerance _xdrug therapy |
650 | 0 | 4 |
_aGlucose Transporter Type 4 _xgenetics |
650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
650 | 0 | 4 |
_aInsulin _xblood |
650 | 0 | 4 | _aLipid Metabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Obese |
650 | 0 | 4 |
_aMuscle Cells _xdrug effects |
650 | 0 | 4 |
_aMuscle Fibers, Skeletal _xdrug effects |
650 | 0 | 4 | _aPhosphorylation |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aThiobarbituric Acid Reactive Substances _xmetabolism |
650 | 0 | 4 |
_aTriglycerides _xblood |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xblood |
700 | 1 | _aFuruhashi, Keisuke | |
700 | 1 | _aIto, Katsuki | |
700 | 1 | _aNagaoka, Masato | |
700 | 1 | _aYonezawa, Takayuki | |
700 | 1 | _aMiura, Yutaka | |
700 | 1 | _aYagasaki, Kazumi | |
773 | 0 |
_tMolecular nutrition & food research _gvol. 58 _gno. 2 _gp. 267-77 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/mnfr.201300272 _zAvailable from publisher's website |
999 |
_c23091178 _d23091178 |